MedTech
UCD spin-out Aer Therapeutics raises $36m in funding
Company was co-founded by Irishman Prof John Fahy of University of California, San Francisco and Prof Stefan Oscarson of UCD
Aer Therapeutics, a joint University College Dublin (UCD) and University of California, San Francisco (UCSF) spin-out company, has secured $36 million (€32.5 million) in a Series A funding round.
The biopharmaceuticalcompany is developing novel inhaled treatments for muco-obstructive lung diseases.
Funding was received from a syndicate of life science industry investors that includes Canaan, OrbiMed, and Hatteras Venture Partners. Proceeds from the financing will be used to advance the development of AER-01, a novel inhaled ...
